Biologics Commonly Used in Cutaneous Crohn's Disease
-
By
-
Andrea Surnit
-
May 27, 2026
-
3 min
By
Andrea Surnit
May 27, 2026
Several FDA decisions across multiple specialties are expected this month.
August 28, 2026
Early recognition of segmental facial lesions prompted diagnosis and multidisciplinary care in an infant with multisystem involvement
April 14, 2026
Nearly 90% of patients who met algorithmic criteria for postacute sequelae of SARS-CoV-2 infection had at least 1 chronic or potentially chronic condition requiring ongoing clinical management.
June 30, 2026